US Patent 11859000 Anti-CCR8 antibodies and uses thereof
Patent 11859000 was granted and assigned to Vaccinex, Inc on January, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11859000 Anti-CCR8 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
